Retrospective analysis of systemic chemotherapy for unresectable advanced biliary tract cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO ...
HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) -- RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback